Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Watson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
Determining the potency and molecular mechanism of action of insurmountable antagonistsTerry Kenakin, Stephen Jenkinson, Christian Watson
Molecular Pharmacology|January 13, 2005
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitorChristian Watson, Stephen Jenkinson, Wieslaw Kazmierski, et al.
ACS Chemical Neuroscience|August 4, 2012
A simple method for quantifying functional selectivity and agonist biasTerry Kenakin, Christian Watson, Vanessa Muniz-Medina, et al.
The Journal of Biological Chemistry|May 9, 2024
Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1Wangfang Hou, Christian Watson, Ted Cecconie, et al.
Journal of Medicinal Chemistry|September 25, 2008
Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1Wieslaw M Kazmierski, Christopher Aquino, Brian A Chauder, et al.
Journal of Medicinal Chemistry|May 5, 2011
Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profileWieslaw M Kazmierski, Don L Anderson, Christopher Aquino, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
Determining the potency and molecular mechanism of action of insurmountable antagonistsTerry Kenakin, Stephen Jenkinson, Christian Watson
Molecular Pharmacology|January 13, 2005
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitorChristian Watson, Stephen Jenkinson, Wieslaw Kazmierski, et al.
ACS Chemical Neuroscience|August 4, 2012
A simple method for quantifying functional selectivity and agonist biasTerry Kenakin, Christian Watson, Vanessa Muniz-Medina, et al.
The Journal of Biological Chemistry|May 9, 2024
Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1Wangfang Hou, Christian Watson, Ted Cecconie, et al.
Journal of Medicinal Chemistry|September 25, 2008
Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1Wieslaw M Kazmierski, Christopher Aquino, Brian A Chauder, et al.
Journal of Medicinal Chemistry|May 5, 2011
Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profileWieslaw M Kazmierski, Don L Anderson, Christopher Aquino, et al.
Pageof 1